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Ethical statement
This work was approved by the Ethics Commission of the Charité –
Universitätsmedizin Berlin (EA4/110/10).Urinary cell isolation and expansion
Urine was obtained from a female healthy Caucasian donor of
28 years of age. Urinary cells were isolated according to the protocol
described by Zhou et al. (2012). After centrifugation and washing with
PBS (Gibco) the obtained cell pellet was resuspended in primary-
medium containing DMEM high glucose (GIBCO) and HAM's F12
(Biochrom), which were mixed in a 1:1 ratio and supplemented with
2,5 μg/ml amphotericin B (Biochrom), 10% (v/v) fetal bovine serum
(FBS, Biochrom), penicillin/streptomycin (P/S, 100 U/ml/100 μg/ml,
Biochrom) and the renal growth media (REGM) SingleQuot kit
(Lonza) and ﬁnally plated on 0,1% w/t gelatin coated (Milipore) plates.
Primary-medium was added for the following three days and after-
wards successively changed to proliferation-medium which was a 1:1
mixture of DMEM high glucose and the REBM basal medium supple-
mented with 5% (v/v) FBS, 1,25 mM GlutaMax™ , 0,5% (v/v) non-
essential amino acids (NEAA, Gibco), P/S (50 U/ml, 50 μg/ml),
2,5 ng/ml basic ﬁbroblast growth factor (bFGF), 2,5 ng/ml platelet
derived growth factor (PDGF-AB), 2,5 ng/ml human epidermalthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1.Morphology of primary urinary cells, reprogrammed hiPSCs and pluripotencymarker expression. (A) Phase contrast images of primary urinary cells and (B) generated hiPSCs. (C).
hiPSC lines were stained for the pluripotency markers TRA-1-60, TRA-1-81, SSEA-4, OCT4 and DAPI for staining of nuclei. Scale bars: A, B and: 100 μm, C: 50 μm.
Fig. 2. Analysis of Sendai viral transgene expression in generated hiPSC lines. RT-PCR of
reprogrammed hiPSC lines was performed for the expression of Sendai virus (SeV), SeV-
SOX2, SeV-KLF4, SeV-MYC and SeV-OCT3/4.
Fig. 3. Spontaneous in vitro differentiation of hiPSCs into cells of the three germ layers. (A) EB for
(MIXL1), Goosecoid (GSC), SRY (Sex Determining Region Y)-Box 17 (Sox17), NeuroD, Orthode
Scale bar: 100 μm.
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integration free Sendai virus..., Stem Cell Res. (2016), http://dx.doi.org/10growth factor (hEGF, all Peprotech) and the REGM SingleQuot
kit. First colonies appeared on day 5. After reaching about 90%
conﬂuency, cells were passaged using trypsin (Biochrom) and re-
plated on gelatin coated dishes in a ratio of 1:10. Cells were frozen
in FBS containing 10% dimethylsulfoxid (DMSO).Reprogramming and hiPSC maintenance
Urinary cells were thawed and cultivated in RPMI (Gibco) medium
supplemented with 10% FBS and 1% P/S on gelatin coated dishes
until reaching conﬂuence of around 90% again. The Sendai virus
(SeV) based non-integration CytoTune™ iPS Reprogramming Kit
(Life Technologies) (Fusaki et al., 2009) was used according to
manufacturer's instructions. First colonies appeared after 10 days. 5 sin-
gle colonies were picked and cultivated under feeder free conditions on
Geltrex (Life Technologies) in TeSR-E8 medium (Stemcell Technolo-
gies) supplemented with 1% P/S. The hiPSCs were passaged every 5–
7 days in a ratio of 1:6. At passage 14, colonies were tested for virus
loss and pluripotency marker expression and one of the 5 colonies
was kept in culture for further analysis. Frozen stocks of the other colo-
nies were kept too.mation and (B) RT-PCR for themarkers NANOG, Brachyury (T),Mix Paired-like Homeobox
nticle homeobox 2 (OTX2) and for glyceraldehyde-3-phosphate dehydrogenase (GAPDH).
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Fig. 4. Karyotyping of hiPSC lines. Karyogramwas determined using the KaryoLite™ BoBs™ Kit. Female and male DNAwith normal karyotypes were used as reference and chromosomal
signals were compared with the tested hiPSC DNA (red: against female, blue: against male DNA). No aneuploidies were detected for the hiPSC line BCRTi005-A.
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hiPSCswere ﬁxed (BD Cytoﬁx) and permeabilized using Perm/Wash
buffer (BD) and stained with antibodies against the pluripotency
markers TRA-1-60 (Novous Biologicals), TRA-1-81 (Novus Biologicals),
OCT-4 PerCP-Cy5.5 (BD) and SSEA-4 FITC (R&D). Subsequently, cell nu-
clei were labeledwith 4′,6-diamidino-2-phenylindole (DAPI, Invitrogen).
The ﬁnal analysis was performed using the High Content Screening
Imaging System Operetta (Perkin Elmer).RNA isolation and cDNA synthesis
Total RNAwas extracted (Qiagen RNAMini Kit) and transcribed into
cDNA using the SuperScript® III Transcriptase Kit (Life Technologies).Table 2
Primer sequences for pluripotency and germ layer speciﬁcation.Detection of SeV genome and transgenes
After 14 passages, hiPSC lines were tested for SeV residues. PCR was
performed using primers and instructions (Table 1) as recommended
by the manufacturer. As positive control RNA was used from the
reprogramming leftovers. Negative control RNA was obtained fromTable 1
Primer sequences for Sendai viral test.
Target Primer sequence
SeV Forward AAGGTCCCGGTCAAGAAACAG
Reverse CTTCTGCGTCACACCATTGC
SOX2 Forward TAAGGTGGATCTTCAGGTAGC
Reverse CATCTCATTGGTGAGCTCCCT
MYC Forward CTGTTCCCCTCTCTCTGAAGA
Reverse GGCAGAAAAGATGTGTTCCTCC
OCT3/4 Forward AACGCGGAGAAGTGGAACAAG
Reverse CTGTCCGAGTCCAAATCGC
KLF4 Forward GTGGACCGCACGGAATTTG
Reverse GGAGATTCACACCGGAGTCA
Please cite this article as: Rossbach, B., et al., Generation of a human induce
integration free Sendai virus..., Stem Cell Res. (2016), http://dx.doi.org/10the hiPSC line WISCi004-A (IMR90, WiCell), which was lentivirally
reprogrammed from IRM90.4 ﬁbroblasts.
Embryoid body (EB) formation and germ layer differentiation
To test the capacity of the reprogrammed hiPSC line to spontaneous-
ly differentiate into cells of all three germ layers, hiPSCs were harvested
using accutase (Gibco) and seeded in TeSR-E8 supplemented with
10 μm Rock inhibitor (StemCell Technologies) into AggreWell plates
800 (StemCell Technologies). EBs formed within 24 h and were further
cultivated on ultra-low attachment plates (Corning) in KO-DMEM
(Invitrogen) supplemented with 20% Knockout SerumReplacer
(Invitrogen), 1,25 mM GlutaMax™, 1% (v/v) NEAA, 0,2% (v/v) beta-
Mercaptoethanol (Gibco) and P/S (100 U/ml/100 μg/ml) for 10 days.
Medium was changed every 48 h.
EBs were harvested and isolated RNA was transcribed into cDNA.
PCR was performed to analyze the expression of germ layer speciﬁc
genes (Table 2). The following PCR program was used: 96 °C forTarget Primer sequence
NANOG Forward AAGGTCCCGGTCAAGAAACAG
Reverse CTTCTGCGTCACACCATTGC
Brachyuri (T) Forward TAAGGTGGATCTTCAGGTAGC
Reverse CATCTCATTGGTGAGCTCCCT
MIXL1 Forward CTGTTCCCCTCTCTCTGAAGA
Reverse GGCAGAAAAGATGTGTTCCTCC
GSC Forward AACGCGGAGAAGTGGAACAAG
Reverse CTGTCCGAGTCCAAATCGC
SOX17 Forward GTGGACCGCACGGAATTTG
Reverse GGAGATTCACACCGGAGTCA
NEUROD1 Forward GCCCCAGGGTTATGAGACTATCACT
Reverse CCGACAGAGCCCAGATGTAGTTCTT
OTX2 Forward TGTAGAAGCTATTTTTGTGGGTGA
Reverse GAGCATCGTTCCATCTAACTTTTT
GAPDH Forward TTGCCATCAATGACCCCTTCA
Reverse CGCCCCACTTGATTTTGGA
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4 B. Rossbach et al. / Stem Cell Research xxx (2016) xxx–xxx5min, 35 cycles of 96 °C for 30 s, 56 °C for 30 s and 72 °C for 30 s. Final
elongation was done at 72 °C for 7 min.
Karyogram
For the detection of chromosomal aberrations, the KaryoLite™
BoBs™ Kit was used supplied by Perkin Elmer (Lund et al., 2012).
Genomic DNA was processed according to the manufacturer's instruc-
tions. Female and male controls were used in parallel. The ﬂuorescent
signal was detected using the Bio-Plex 200 system (BioRad) and ﬁnally
analyzed using the Perkin Elmer software BoBsoft™.
Fingerprinting
Short Tandem Repeat (STR) analysis was performed to identify the
purity of these cell lines. DNA was extracted (Qiagen) from the hiPSCs
and the corresponding primary cells. The genome was analyzed for
10 different loci out of the Combined DNA Index System (CODIS):Please cite this article as: Rossbach, B., et al., Generation of a human induce
integration free Sendai virus..., Stem Cell Res. (2016), http://dx.doi.org/10D16S539, D7S820, CSF1PO, D5S818, TPOX, D13S317, vWA, HUMTH01,
DXS101 and DYS393.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.scr.2016.09.002.
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